Abstract: The invention relates to a self-emulsifiable liquid composition intended to be diluted in an aqueous intermediate solution and then incorporated into the drinking water of livestock animals, and also to the use of such a composition. The invention is characterized in that the composition comprises at least—between 1% and 12% by weight of the florfenicol active ingredient, relative to the total volume of the composition; —at least 50% by weight, relative to the total volume of the composition (p/v), of a mixture of C8-C10 saturated polyglycosylated glycerides having an HLB (hydrophilic-lipophilic balance) of less than 16; and—at least 5% by weight, relative to the total volume of the composition (p/v), of a surfactant.

Abstract: The invention relates to a self-emulsifiable liquid composition intended to be diluted in an aqueous intermediate solution and then incorporated into the drinking water of livestock animals, and also to the use of such a composition. The invention is characterized in that the composition comprises at least—between 1% and 12% by weight of the florfenicol active ingredient, relative to the total volume of the composition; —at least 50% by weight, relative to the total volume of the composition (p/v), of a mixture of C8-C10 saturated polyglycosylated glycerides having an HLB (hydrophilic-lipophilic balance) of less than 16; and—at least 5% by weight, relative to the total volume of the composition (p/v), of a surfactant.

Abstract: Composition and system for oral administration of chemicals or medicaments, and applications thereof (for example as medicament, dietetic product, food product, bait). Said composition comprises essentially (a) from 3% to 20% by weight of at least one water-insoluble polymer selected from the polyamides and ethylene copolymers such as ethylene/vinyl acetate; (b) from 35% to 60% by weight of lipidic substances, at least one of these lipidic substances being solid at room temperature, the melting point of the solid lipidic substance(s) being lower than that of the polymer(s); (c) from 5% to 45% of at least one paletable substance; (d) from 0% to 50% of another suitable complementary ingredient. Said composition can be obtained by (i) melting of the solid lipidic substances at a temperature lower than the melting point of the polymer(s), and (ii) mixing of the polymer(s) and the other constituents at the same temperature as for (i). A method of preparing said systems and composition is also disclosed.

Abstract: A dosage form for orally administering chemical or medicinal substances such as vitamins, trace elements, amino acids, nutritive substances, vaccines, etc., to domestic or wild animals, and a method for preparing same, are disclosed. Said dosage form includes: a porous water-soluble central core containing binders selected from polypeptides, polysaccharides, polymers and colloids, and/or diluents selected from polyols, metal oxides, carbonates, phosphates and microcrystalline cellulose, and an effective amount of at least one bioactive substance; and a palatable hydrophobic outer layer containing at least one lipid substance selected from fatty alcohols, fatty acids, glycerol esters, hydrogenated oils, waxes, paraffin, lanolin, coconut oil and fatty acid salts; a polymeric agent for modulating the disintegration and adhesion of said outer layer, and natural or synthetic palatable substances.

Abstract: Stabilized pulverulent active agents, compositions containing them and also process for obtaining them; such stabilized active agents enable dry and stable pharmaceutical, dietary, nutritional or cosmetic compositions to be obtained, in which the properties of the said active agents are neither modified nor impaired. Such stabilized active agents are stabilized by coating with a coating composition comprising:-- at least one film-forming agent, in proportions of between 2 and 25% by weight of the final mass, selected from polyvinylpyrrolidones (povidone), polyvinyl alcohols, vinylpyrrolidone/vinyl acetate copolymer, vinylpyrrolidone/polyvinyl alcohol copolymer, cellulose derivatives such as cellulose acetate, cellulose acetate phthalate, cellulose butyrate, ethylcellulose and methylcellulose, acrylic and methacrylic polymers and copolymers and vegetable, animal or synthetic waxes, and-- at least one pore-forming agent, in proportions of between 0 and 5%, by weight preferably of between 0.

Abstract: Solid compositions based on plants, capable of being converted to a dry and porous galenic form (lyophilized or equivalent form) which is undivided or powdered. Said dry and porous galenic form comprises a solid composition II consisting ofa solid composition I composed of:(A) one or more of the plants' active principles included in a homogeneous suspension of fresh or dry plants obtained by (a) cleaning and/or drying of the plant or part of the plant, (b) cryocomminution at a temperature below 0.degree. C. until a particle size of less than about 100 .mu.

Abstract: Hydroquinone amino-acid esters having formula (I), pharmaceutical or cosmetic compositions containing them, particularly dermatological compositions having pigment-removing activity, and the pharmaceutical, cosmetic or aesthetic uses thereof. The preparation of these novel hydroquinone esters from natural amino-acid derivatives is also described.

Abstract: Amino acid esters of cycloaliphatic alcohols of the formula: ##STR1## wherein A is cyclohexyl, cyclohexenyl, cyclopentyl, or cyclopentenyl, substituted with from one to three radicals selected from the group consisting of methyl, ethyl and ethenyl. These compounds are useful in treating lipemic disorders.

Abstract: Amino acid esters of cycloaliphatic alcohols of the formula: ##STR1## wherein A is cyclohexyl, cyclohexenyl, cyclopentyl and cyclopentenyl, substituted with from one to three radicals which are methyl, ethyl, and/or ethenyl. These amino acid esters have hypolipemic properties.

Abstract: Drugs with high anticonvulsant and analgesic activities constituted by symmetrical .beta.-dialkoxyiminocycloalklene derivatives in which the imine double bonds are conjugated with the cyclic double bond or bonds belonging to one or more fused benzene rings.

Abstract: Alkylcarboxamides of pyridylalkylamines, useful in human and verterinary medicine, correspond to the general formula I: ##STR1## wherein n=0 or 1,R.sub.3 represents an alkyl group of C.sub.1 to C.sub.3 or a hydrogen atom,R.sub.1 represents a hydrogen atom,R.sub.2 represents a group: ##STR2## in which: X and Y are different,X and Y each represent a linear or branched saturated or unsaturated hydrocarbon chain comprising from 1 to 16 carbon atoms;X and Y together determine a saturated or unsaturated cyclic radical substituted or not comprising from 3 to 12 carbon atoms.

Abstract: The present invention relates to novel antibacterial agents, corresponding to the following general formula I ##STR1## in which: Q represents an aromatic ring,X represents a hydrogen atom or a linear or branched alkyl group,Y represents a linkage or an alkyl group,Z represents a hydrogen atom, an alkyl, aralkyl or heteroalkyl group.These compounds constitute anti-bacterial agents with multiple pharmacological activity.

Abstract: The present invention relates to new adamantanamine derivatives.These derivatives correspond to the general formula I: ##STR1## in which: R represents hydrogen or a substituted or unsubstituted, linear or branched alkyl radical containing from 1 to 7 carbon atoms.Drugs possessing anticonvulsant properties.

Abstract: The present invention relates to new N-acyl derivatives of amino acids.These derivatives correspond to the general formula I below: ##STR1## in which A represents a linear or branched, saturated hydrocarbon radical containing from 1 to 6 carbon atoms or a saturated ring containing 6 carbon atoms,X represents a --COOH radical, a --COOAlkyl radical (alkyl from C.sub.1 to C.sub.4), a hydrogen atom or a --CH.sub.3 group when Y is --COOH or --COOAlkyl,Y represents a --COOH radical, a --COOAlkyl radical (alkyl from C.sub.1 to C.sub.4), an --NH.sub.2 group, an --SH group, an --SCH.sub.3 group, a --NH--CH(.dbd.NH)--NH.sub.2 group, a substituted or unsubstituted phenyl group, an indolin-3-yl group or a 5-hydroxyindolin-3-yl group, andQ represents an optionally substituted aromatic ring or an optionally substituted heterocycle containing 1 or 2 nitrogen atoms.Drugs having an antiallergic action.

Abstract: The present invention relates to new dipeptides of L-5-hydroxytryptophan.They correspond to the general formula below: ##STR1## in which: X represents hydrogen or a lower acyl radical andQ represents a free or esterified aminoacid radical.Application: drugs for combating disorder of the serotoninergic system.